Michael Morrison
Optometrist · Mahnomen, MNNPI 1164457750
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,101 of the $5,074 with a category attached, or 80.8%. Biotissue Holdings Inc. accounts for 94.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $4,426 and has fallen 92.9% since, to $312 in 2025. Among optometrist clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $137.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$5K
- Alcon$108
- Maculogix, Inc.$58
- Glaukos Corporation$34
- AbbVie$26
- Novartis$20
- plus $43 from 3 others
What the payments were for
- Travel & lodging$4,10181%
- Food & beverage$97219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 20 | $4,785 |
| Alcon | 8 | $108 |
| Maculogix, Inc. | 2 | $58 |
| Glaukos Corporation | 1 | $34 |
| AbbVie | 2 | $26 |
| Novartis | 1 | $20 |
| Johnson & Johnson Vision Care, Inc. | 1 | $15 |
| The Cameron-ehlen Group, Inc. | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $14 |
How this compares
$5,074 in reported general payments places this provider in the 95th percentile of 826 optometrist providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 27 | $21,139 |
| LumiganBimatoprost | 37 | $18,710 |
| Travoprost | 62 | $9,114 |
| Latanoprost | 374 | $6,752 |
| CombiganBrimonidine Tartrate/Timolol | 13 | $4,590 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 16 | $2,908 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 116 | $2,109 |
| Timolol Maleate | 104 | $1,780 |
| Dorzolamide Hcl | 24 | $583 |
| Prednisolone Acetate | 18 | $581 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $420 |
| Brimonidine Tartrate | 13 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $26 | $44,43977 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 826 optometrist providers in Minnesota.
Other optometrist in Mahnomen
- Jacob LangStillwater$264K
- Britt GustafsonEden Prairie$236K
- Gina WesleyMedina$232K
- Nicholas ColatrellaSartell$84K
- Trevor FossoSartell$45K
- Mathew WalkerAlexandria$43K
- Joshua HanenMinneapolis$40K
- Zachary HollandEdina$36K
- Patrick WellikApple Valley$15K
- Paul HammondCoon Rapids$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.